Better Tests, Better Care: Improved Diagnostics for Infectious Diseases
By A. Caliendo, David N. Gilbert, C. Ginocchio, K. Hanson, L. May, Thomas C. Quinn, F. Tenover, D. Alland, A. Blaschke, Robert A. Bonomo and 8 more. Clinical Infectious Diseases, 2013
615 citations recorded by the source corpus.
In this IDSA policy paper, we review the current diagnostic landscape, including unmet needs and emerging technologies, and assess the challenges to the development and clinical integration of improved tests. To fulfill the promise of emerging diagnostics, IDSA presents recommendations that address a host of identified barriers. Achieving these goals will require the engagement and coordination of a number of stakeholders, including Congress, funding and regulatory bodies, public health agencies, the diagnostics industry, healthcare systems, professional societies, and individual clinicians.
Subfields: Clinical Biochemistry, Epidemiology, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/f740d98ce77fec7248e5f3b74b5fb19ffc448042
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Phage Therapy in the Postantibiotic Era (2019, background): “Conversely, that specificity also demands accurate diagnosis of the infection and identification of the etiological agent, sometimes to the strain level, a process that can be difficult and time- and resourceconsuming (47).”
- Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children (2015, background): “43,44 Due to ethical and feasibility considerations, invasive procedures to obtain direct lung samples were not commonly performed.”